Home
About
Overview
Sharing Data
ORCID
Help
History (63)
Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia.
Melanocytes, melanocyte stem cells, and melanoma stem cells.
When cell biology grew up.
The University of Chicago Pritzker School of Medicine.
A national strategy to develop pragmatic clinical trials infrastructure.
See All 63 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A national strategy to develop pragmatic clinical trials infrastructure.
A national strategy to develop pragmatic clinical trials infrastructure. Clin Transl Sci. 2014 Apr; 7(2):164-71.
View in:
PubMed
subject areas
Health Planning Guidelines
Humans
Pragmatic Clinical Trials as Topic
Program Development
United States
authors with profiles
Jerry A. Krishnan